Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats

Molecular and Cellular Biochemistry

Volumn 179, Issue 1-2, 1998, Pages 27-34

  Battell, Mary L ^a   Delgatty, Heather L M ^a   McNeill, John H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; Heart function; Insulin like; Selenium

Indexed keywords

GLUCOSE; INSULIN; SELENATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART FUNCTION; INSULIN RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; EATING; GLUCOSE; GLUCOSE TOLERANCE TEST; HEART; HEART FUNCTION TESTS; INSULIN; LIPIDS; RATS; RATS, WISTAR; SELENIUM COMPOUNDS; VANADIUM;

ANIMALIA;

EID: 0031908442     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006819227506     Document Type: Article

References (38)

1. Ezaki O: The insulin-like effects of sodium selenate in rat adipocytes. J Biol Chem 265: 1124-28, 1990
2. McNeill JH, Delgatty HLM, Battell ML: Insulinlike effects of sodium selenate in streptozotocin diabetic rats. Diabetes 40: 1675-78,1991
3. Becker DJ, Reul B, Ozcelikay AT, Buchet JP, Henquin J-C, Brichard SM: Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 39: 3-11, 1996
4. Ghosh R, Mukherjee B, Chatterjee M: A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res 25: 165-171, 1994
5. Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474-1477, 1985
6. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH: Oral vanadyl sulphate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904-H911, 1989
7. Ramanadham S, Brownsey RW, Cros GH, Mongold JJ, McNeill JH: Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment. Metabolism 38: 1022-1028, 1989
8. Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J: Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126: 2728-2732, 1990
9. Brichard SM, Okitolonda W, Henquin JC: Long term improvement in glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048-2053, 1988
10. Meyerovitch J, Farfel Z, Sack J, Shechter Y: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J Biol Chem 262: 6658-6662, 1987
11. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973
12. World Health Organization: Selenium Environmental Health Criteria 58: World Health Organization Geneva, 1987
13. Chen X, Yang G, Chen J, Chen X, Wen Z, Ge X: Studies on the relations of selenium and Keshan disease. Biol Trace Elem Res 2: 91-107, 1980
14. Hawkes WC, Wilhelmsen EC, Tappel AL: Abundance and tissue distribution of selenocystine-containing proteins in the rat. J Inorg Biochem 23: 77-92, 1985
15. Behne D, Kyriakopoulos A, Meinhold H, Kohrle J: Identification of type 1 iodothyronine 5′-deiodinase as a selenoenzyme. Biochem Biophys Res Comm 173: 1143-1149, 1990
16. Behne D Kyriakopoulos A: Effects of dietary selenium on the tissue concentrations of type 1 iodothyronine 5′-deiodinase and other selenoproteins. Am J Clin Nutr Suppl 57: 310S-312S, 1993
17. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 59: 8-13, 1979
18. Opie LH: Effect of fatty acid on contractility and rhythm of the heart. Nature (London) 227: 1055-1066, 1970
19. Skipp JC, Menahan LA, Crass III MF, Chaudhuri SN: Heart triglycerides in health and disease. In: NS Dhalla (ed). Recent Advances in Studies on Cardiac Structure and Metabolism. Vol 3., University Park Press, Baltimore, MD, 1973, pp 179-204
20. Vadlamudi RVSV, Rodgers RL, McNeill JH: The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 60: 902-911, 1982
21. Tahiliani AG, Vadlamudi RVSV, McNeill JH: Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment. Can J Physiol Pharmacol 61: 516-523, 1983
22. Turan B, Dalay N, Afrasyap L, Delilbasi E, Sengun Z, Sayal A, Isimer A: The effects of selenium supplementation on antioxidative enzyme activities and plasma and erythrocyte selenium levels. Acta Physiol Hung 81: 87-93, 1993
23. Zhong G-G, Jiang Y, Li ZB, Zhang BG, Zhang WJ, Yue G: Protective action of selenium and manganese on xanthine and xanthine oxidase induced oxidative damage to cultured heart cells. Chin Med J 103: 735-742. 1990
24. Halverson AW, Palmer IS, Guss PL: Toxicity of selenium to post weanling rats. Toxicol Appl Pharmacol 9: 477-484, 1966
25. Tinsley IJ, Harr JR, Bone JF, Weswig PH, Yamamoto RS: Selenium toxicity in rats. I. Growth and longevity. In: OH Muth, JE Oldfield and PH Weswig (eds). Selenium in Biomedicine. The Avi Publishing Co. Inc., Westport, Conn., 1967, pp 141-152
26. Jacobs MM, Forst C: Toxicological effects of sodium selenite in Sprague Dawley rats. J Toxicol Environ Health 8: 575-585, 1981
27. Franke KW, Moxon AL: A comparison of the minimum fatal dose of selenium, tellurium, arsenic, and vanadium. J Pharmacol Exp Ther 58: 454-459, 1936
28. Schroeder HA Mitchener M: Selenium and tellurium in rats: effects on growth, survival, and tumors. J Nutr 101: 1531-1540, 1971
29. Smith MI, Westfall BB, Stohlman EF Jr: The elimination of selenium and its distribution in the tissues. U.S. Publ Health Rep 52: 1171-1177, 1937
30. Thorlacius-Ussing O: Selenium induced growth retardation. Histochemical and endocrinological studies on the anterior pituitaries of selenium treated rats. Danish Med Bull 37: 347-358, 1990
31. Tolman EI, Barris E, Burns M, Pansini R, Partridge R: Effects of vanadium on glucose metabolism in vitro. Life Sci 25: 1159-1165, 1979
32. Furnsinn C, Leitner G, Roden M, Osterode W, Waldhausl W: Improved glucose tolerance by acute vanadate but not selenate exposure in genetically obese rats (fa/fa). Intern J Obesity 19: 458-463, 1995
33. Tamura S, Brown TA, Dubler RE, Larner J: Insulin-like effects of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor. Biochem Biophys Res Comm 113: 80-86, 1983
34. Shisheva A Shechter Y: Role of cytosolic tyrosine kinase in mediating insulinlike actions of vanadate in rat adipocytes. J Biol Chem 268: 6463-6469, 1993
35. Rodrigues BB, McNeill JH: Cardiac function in spontaneously hypertensive diabetic rats. Am J Physiol 251: H571-H580, 1986
36. Rodrigues BB, Goyal RK, McNeill JH: Effects of hydralazine on streptozotocin induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol Exp Ther 237: 292-299, 1986
37. Koehler H, Peters H-J, Pankau H, Duck H-J: Selenium in cardiology and angiology. Biol Trace Elem Res 15: 157-167, 1988
38. Konz K-H, Haap M, Hill KE, Burk RF, Walsh RA: Diastolic dysfunction of perfused rat hearts induced by hydrogen peroxide. Protective effect of selenium. J Mol Cell Cardiol 21: 789-795, 1989